Femme et Homme
- | Pays :
- United States
- Netherlands
- France
- Les 2 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a phase I/II pediatric dose-ranging study that will evaluate the safety, tolerability, clinical response, pharmacokinetics and pharmacodynamics of midostaurin in patients <18 years of age who have relapsed or refractory acute leukemias that may benefit from administration of midostaurin, including MLL-rearranged ALL and FLT3 positive AML.
Critère d'inclusion
- Acute Myeloid Leukemia ,Acute Lymphoblastic Leukemia